يحاول ذهب - حر
Novo moves HC to restrain Sun Pharma
December 10, 2025
|Mint New Delhi
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
The Danish drugmaker on Tuesday moved the Delhi High Court, seeking to restrain domestic giant Sun Pharmaceutical Industries from launching its generic version of semaglutide, a widely prescribed drug for diabetes and weight loss.
The matter was heard briefly by a bench headed by justice Tejas Karia, who transferred the case to the bench already hearing Novo's parallel litigation against Dr. Reddy’s Laboratories and Natco Pharma concerning the same patent.
The plea is likely to be taken up today before justice Manmeet Pritam Singh Arora, who last week allowed Dr. Reddy's Laboratories to export semaglutide to non-patent nations.
هذه القصة من طبعة December 10, 2025 من Mint New Delhi.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint New Delhi
Mint New Delhi
Hormuz reopening looks unlikely without a ceasefire
US President Donald Trump is desperate to reopen the Strait of Hormuz to ease a growing global energy crisis.
2 mins
March 18, 2026
Mint New Delhi
Colby to lead visiting US team later this month
Top US defence official Elbridge Colby will visit India as the head of a delegation later this month to inject momentum into the two countries’ defence ties after months of diplomatic tensions.
1 min
March 18, 2026
Mint New Delhi
Should you upgrade to Samsung's new behemoth?
The Samsung Galaxy S26 Ultra is a massive, feature-rich smartphone, with a new safety feature. But are the S26's upgrades enough?
4 mins
March 18, 2026
Mint New Delhi
Policymakers must steer clear of gimmicks as oil prices go up
Conservation calls that recall the 70s’ oil shock are unlikely to help
3 mins
March 18, 2026
Mint New Delhi
Union Bank eyes ₹7,500 cr in first infra bond issue
A day after securing board approval to raise ₹20,000 crore via infrastructure bonds, Union Bank of India announced its plans to issue the first ₹7,500 crore tranche of 10-year bonds on Friday, three merchant bankers told Mint.
1 mins
March 18, 2026
Mint New Delhi
The brutal math of full-time trading—and why most fail
Most retail traders lose money—91% in derivatives and 70% in intraday equity cash trading
5 mins
March 18, 2026
Mint New Delhi
MARKETS REWARD DISCIPLINE: WHY STAYING INVESTED MATTERS MORE THAN TIMING
Consistency and patience tend to deliver better outcomes than constant buying and selling driven by market sentiment.
3 mins
March 18, 2026
Mint New Delhi
The Leela buys Coorg resort for ₹560 crore
The Leela Palaces, Hotels and Resorts has bought an ultra-luxury resort in Coorg for up to ₹560 crore to expand its wellness portfolio.
1 min
March 18, 2026
Mint New Delhi
OpenAI to cut back on side projects in push to ‘nail’ core business
OpenAI’s top executives are finalizing plans for a major strategy shift to refocus the company around coding and business users, recognizing that a “do everything all at once” strategy has put them on the defensive.
3 mins
March 18, 2026
Mint New Delhi
IDBI sale junked as bids stayed below ₹70,000 cr
Govt may hold on to its stake for a longer period before deciding on divestment
2 mins
March 18, 2026
Listen
Translate
Change font size